TenaTac is approved as a Class III medical device in Europe and patented worldwide.
TenaTac® is a novel surgical haemostat that controls bleeding and adheres securely to the wound site to prevent displacement, reducing the risk of post-operative bleeding.
TenaTac has many advantages over current surgical haemostats
Easy to use/use dry
Strong adhesion
Fills uneven defects
Defies gravity
Stays in place for post-operative security
No blood derived proteins
No chemically reactive ingredients
Biocompatible gelatin
How it works
TenaTac is applied dry and works by conforming to the wound and minimising shear forces in order to greatly increase adhesion and prevent dislodgement during or after surgery
1
2
3